Savage D - Search Results

1

Discovery and synthesis of novel 4-aminopyrrolopyrimidine Tie-2 kinase inhibitors for the treatment of solid tumors.

Arcari JT, Beebe JS, Berliner MA, Bernardo V, Boehm M, Borzillo GV, Clark T, Cohen BD, Connell RD, Frost HN, Gordon DA, Hungerford WM, Kakar SM, Kanter A, Keene NF, Knauth EA, Lagreca SD, Lu Y, Martinez-Alsina L, Marx MA, Morris J, Patel NC, Savage D, Soderstrom CI, Thompson C, Tkalcevic G, Tom NJ, Vajdos FF, Valentine JJ, Vincent PW, Wessel MD, Chen JM. Arcari JT, et al. Among authors: savage d. Bioorg Med Chem Lett. 2013 May 15;23(10):3059-63. doi: 10.1016/j.bmcl.2013.03.012. Epub 2013 Mar 21. Bioorg Med Chem Lett. 2013. PMID: 23566514

2

A novel class of antitumour agents. I. Chemistry and animal experiments.

Savage DS, Emminger A, Mohr U. Savage DS, et al. Cancer Lett. 1977 Mar;2(4-5):267-72. doi: 10.1016/s0304-3835(77)80031-1. Cancer Lett. 1977. PMID: 45729

3

A novel class of antitumour agents. II. In vitro testing.

Emminger A, Kahmann E, Savage DS. Emminger A, et al. Among authors: savage ds. Cancer Lett. 1977 Mar;2(4-5):273-8. doi: 10.1016/s0304-3835(77)80032-3. Cancer Lett. 1977. PMID: 45730

4

A novel class of antitumour agents. III. Morphological findings in treated cells.

Emminger A, Savage DS. Emminger A, et al. Among authors: savage ds. Cancer Lett. 1977 Sep;3(3-4):157-62. doi: 10.1016/s0304-3835(77)95248-x. Cancer Lett. 1977. PMID: 902253

5

Research and development of aminosteroid neuromuscular blocking agents: past and future.

Marshall RJ, Muir AW, Sleigh T, Savage DS. Marshall RJ, et al. Among authors: savage ds. Eur J Anaesthesiol Suppl. 1995 Sep;11:5-10. Eur J Anaesthesiol Suppl. 1995. PMID: 8557007 Review.

6

The neuromuscular and autonomic blocking activities of pancuronium, Org NC 45, and other pancuronium analogues, in the cat.

Durant NN, Marshall IG, Savage DS, Nelson DJ, Sleigh T, Carlyle IC. Durant NN, et al. Among authors: savage ds. J Pharm Pharmacol. 1979 Dec;31(12):831-6. doi: 10.1111/j.2042-7158.1979.tb13675.x. J Pharm Pharmacol. 1979. PMID: 43368

7

The emergence of ORG NC 45, 1- [2 beta,3 alpha,5 alpha,16 beta,17 beta)-3, 17-bis(acetyloxy)-2-(1-piperidinyl)-androstan-16-yl]-1-methylpiperidinium bromide, from the pancuronium series.

Savage DS, Sleigh T, Carlyle I. Savage DS, et al. Br J Anaesth. 1980;52 Suppl 1:3S-9S. doi: 10.1093/bja/52.suppl_1.3s. Br J Anaesth. 1980. PMID: 6107102 Free article.

8

An overview of the pharmacology of rocuronium bromide in experimental animals.

Marshall RJ, Muir AW, Sleigh T, Savage DS. Marshall RJ, et al. Among authors: savage ds. Eur J Anaesthesiol Suppl. 1994;9:9-15. Eur J Anaesthesiol Suppl. 1994. PMID: 7925216

9

Pancuronium bromide and other steroidal neuromuscular blocking agents containing acetylcholine fragments.

Buckett WR, Hewett CL, Savage DS. Buckett WR, et al. Among authors: savage ds. J Med Chem. 1973 Oct;16(10):1116-24. doi: 10.1021/jm00268a011. J Med Chem. 1973. PMID: 4356139 No abstract available.

10

18-Norpregna-8,11,13-trienes: reaction of 16alpha, 17alpha-epoxypregn-8-en-11-ones with Lewis acids.

Hewett CL, Redpath J, Savage DS. Hewett CL, et al. Among authors: savage ds. J Chem Soc Perkin 1. 1975;(13):1288-92. J Chem Soc Perkin 1. 1975. PMID: 1171888 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

981 results

Search Page

Filters